HOW IT WORKS

Move quickly
with confidence,
from day 1

With ImpriMed as your first step, you’ll have the most advanced science at work for you from the very beginning.

A woman gently holding her dog
A young scientist looking through a microscope

What we do

ImpriMed provides a personalized prediction profile that tells you which drugs are most likely to successfully treat your pet's cancer.

Because every day counts in the treatment of canine blood cancers, we make sure to test and analyze your pet’s cancer so your vet receives our recommendations within a week. Then you and your doctor can decide on the best treatment for your pet.

Learn about our science

Collect

Your vet sends us samples of your dog’s tumor and blood via overnight shipping.

A scientist researching cancer cell at a lab

Test & Predict

We test commonly used anticancer drugs on a small sample of your pet's live cancer cells to determine which drugs work best. These test results are combined with other information about your pet, and AI is used to generate a precision medicine report for your veterinarian.

A veterinarian reviewing ImpriMed's service report to give a personalized treatment to her patient

REPort

In 7 days, we send your vet a comprehensive report compiled using cutting-edge biological techniques and advanced AI.

A veterinarian reviewing ImpriMed's service report to give a personalized treatment to her patient
A canine cancer patient receiving personalized treatment with ImpriMed

Personalize

Together, you and your vet decide on the best personalized treatment options for your dog.

Every day Counts

When your dog has cancer, time is of the essence. Learn how ImpriMed helps in the fight against lymphoma in this short video!

Get Started

Frequently asked questions

For Pet Parents

What major services does ImpriMed offer?

ImpriMed offers personalized medicine services that help veterinary oncologists to diagnose and treat canine lymphoma or leukemia.
There are 4 levels of service:

  • Personalized Prediction Profile: The Personalized Prediction Profile is a report that helps your oncologist to pick the best cancer treatment options for your pet.  The report predicts how well your pet will respond to different anticancer drugs.  The predictions are based on ImpriMed's anticancer drug testing technology and artificial intelligence software.  Our drug testing technology measures how your pet's live cells respond to anticancer drugs.
  • Immunoprofile: Canine lymphoma is a diverse disease with variable prognoses. The identification of an Immunoprofile is important to predict tumor behavior for the routine clinical management of patients. ImpriMed uses flow cytometry and PCR by Antigen Receptor Rearrangements (PARR) to gain insight into tumor type and helps your oncologist to tailor your dog’s treatment.
  • Flow cytometry
  • PARR

Why do oncologists recommend ImpriMed services?

When your pet has cancer, time is of the essence. But each cancer and each pet is different, so finding the right anticancer drug can be a slow and difficult process. ImpriMed helps oncologists find a therapy tailored to your individual pet with fewer difficulties, enabling you to reduce the amount of time that your pet is suffering and to find a treatment that could help your pet to live longer.

For which cancers can I order ImpriMed services?

We currently offer our services for dogs with blood cancers such as lymphoma and leukemia.

How do ImpriMed services work?

Your doctor will collect a sample of your dog’s tumor and ship it to our state-of-the-art lab. On receipt at our lab, we process the sample and test your dog’s cancer cells to find the precise type of cancer, and if the drug response prediction is ordered, we next test against a panel of drugs that are selected by your veterinarian. Within 7 days we send a personalized report to your vet, so you and your vet can see the drugs that work best for your dog.

Is sample collection invasive?

All samples for ImpriMed services are collected in a safe and humane manner. Veterinary oncologists need to collect two samples, a fine needle aspiration (FNA) and a blood sample for lymphoma patients, and just a blood sample for leukemia patients. The FNA procedure withdraws a small number of cancer cells from your dog’s lymph nodes (tumor). It is commonly used and minimally invasive.

How can I request ImpriMed services?

Ordering services is easy. Our service can only be ordered by a veterinarian, so in order to try our service:

  • First, we need you to discuss our services with your veterinarian the next time you visit the hospital. Download a discussion guide here.
  • If the oncologist is willing to use our service, please instruct them to email us so that we can send the required supplies with more detailed information.
  • After our supplies and information are received, your doctor will set an appointment for your dog, collect a sample using our supplies, and send the sample to our lab.

What is the turnaround time?

The turnaround time for our services is 3-7 days from sample collection.

What are the prices for ImpriMed services?

The retail price for pet parents varies depending on the veterinarian.

What anticancer drugs can I get predictions for if my dog has lymphoma?

The Personalized Prediction Profile for canine blood cancer includes 13 drugs: Doxorubicin, Cyclophosphamide, Vincristine, Prednisone, Rabacfosadine (Tanovea®), L-Asparaginase, Lomustine, Vinblastine, Mitoxantrone, Mechlorethamine, Dexamethasone, Chlorambucil, and Melphalan.

I would like to donate my pet’s cancer cells to ImpriMed.

Donating cells to research is immensely helpful to ImpriMed. We gratefully accept cancer cells or tissue donations from canine and feline cancer patients. Each donation will help advance our cancer research in pets. We appreciate your willingness to contribute to science and research. Please email info@imprimedicine.com to get started.

Testimonials

Vets Love ImpriMed

The study of new diagnostics and treatments for spontaneous cancer in pets has the potential to benefit our individual veterinary patients, animals with cancer as a whole, and, owing to their similarity, potentially shed new light into the diagnosis and therapy of human cancers as well. This is the basis of Comparative Oncology.
A profile image of Dr. Douglas Thamm

Dr. Douglas Thamm

VMD, MS, DACVIM (O)
I think personalized medicine is the way of the future. Being able to say, this is the weak spot of your cancer, we’re going to exploit that and not give it any chance to come back? That’s the goal. If we can avoid drugs that don’t work, we should. If we can identify better working drugs, we should.
A profile image of Dr. Kevin Choy, Medical Oncology Consultant at ImpriMed, Inc.

Dr. Kevin Choy

BS, BVSc, MS, DACVIM (O)
I have been working with ImpriMed for 3 years now. The oncologists and oncology nurses in SAGE Dublin offer ImpriMed when we have a canine lymphoma patient. We all feel this is a great way to contribute to advancements in canine lymphoma research.
A profile image of Dr. Wendi Velando Rankin, Medical Advisor at ImpriMed, Inc.

Dr. Wendi Velando Rankin

DVM, MS, DACVIM (O)